SNX2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.77395900588817E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.98520019604132E-10 |
Normal-vs-Stage2 |
2.0466999999913E-05 |
Normal-vs-Stage3 |
9.99200722162641E-16 |
Normal-vs-Stage4 |
1.71829217521235E-12 |
Stage1-vs-Stage2 |
6.561400E-01 |
Stage1-vs-Stage3 |
2.03529999999175E-05 |
Stage1-vs-Stage4 |
3.80360000000746E-05 |
Stage2-vs-Stage3 |
4.418400E-02 |
Stage2-vs-Stage4 |
2.135700E-02 |
Stage3-vs-Stage4 |
6.621800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.660116488722E-12 |
Normal-vs-AfricanAmerican |
7.08839997809463E-09 |
Normal-vs-Asian |
6.483600E-03 |
Caucasian-vs-AfricanAmerican |
4.666800E-01 |
Caucasian-vs-Asian |
7.723400E-01 |
AfricanAmerican-vs-Asian |
9.983400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.06181771445335E-14 |
Normal-vs-Female |
9.10982400625926E-12 |
Male-vs-Female |
6.831200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.88040000021128E-07 |
Normal-vs-Age(41-60Yrs) |
9.72320002290417E-11 |
Normal-vs-Age(61-80Yrs) |
1.63813407283442E-12 |
Normal-vs-Age(81-100Yrs) |
1.388530E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.353170E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.411000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.669600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.865200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.680800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.883400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.266220E-01 |
Normal-vs-Grade 2 |
1.1820000533902E-09 |
Normal-vs-Grade 3 |
1.87161397491309E-12 |
Normal-vs-Grade 4 |
1.62592161956354E-12 |
Grade 1-vs-Grade 2 |
1.834650E-01 |
Grade 1-vs-Grade 3 |
3.816000E-02 |
Grade 1-vs-Grade 4 |
6.018500E-04 |
Grade 2-vs-Grade 3 |
3.866300E-02 |
Grade 2-vs-Grade 4 |
9.51530000015133E-07 |
Grade 3-vs-Grade 4 |
8.602200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.41439999995696E-06 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
9.06659969324153E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.12641015906456E-12 |
Normal-vs-N1 |
3.37240000036765E-07 |
N0-vs-N1 |
3.412400E-02 |
|
|